MIRA INFORM REPORT

 

 

Report Date :

08.02.2014

 

IDENTIFICATION DETAILS

 

Name :

HETERO LABS LIMITED (W.e.f. 30.05.1997)

 

 

Formerly Known As :

PHARMASIA LABORATORIES PRIVATE LIMITED (w.e.f. 30.12.1992)

 

PERMILA DRUGS PRIVATE LIMITED

 

 

Registered Office :

7-2-A2, Hetero Corporate Industrial Estate, Sanathnagar, Hyderabad – 500018, Andhra Pradesh

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

10.03.1989

 

 

Com. Reg. No.:

01-009723

 

 

Capital Investment / Paid-up Capital :

Rs. 13.320 Millions

 

 

CIN No.:

[Company Identification No.]

U24110AP1989PLC009723

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

HYDP00777A

 

 

PAN No.:

[Permanent Account No.]

AAACH5506R

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer of Active Pharmaceutical Ingredients (APIs) and Finished Dosages Formulations (FDF).

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (54)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 45000000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Exist

 

 

Comments :

Subject is a part of Hetero Group, it is a well-established company having fine track record.

 

Financial position of the company appears sound. Directors are reported to be experienced and respectable businessmen.

 

Trade relations are reported as fair. Business is active. Payments are reported to be regular and as per commitment.

 

The company can be considered good for normal business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – December 1, 2013

 

Country Name

Previous Rating

(30.09.2013)

Current Rating

(01.12.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

The services sector, the largest contributor to India’s GDP, contracted for the sixth consecutive month in December, as orders dipped. However, hiring has risen.  Direct tax collections rose 12.3 % during the April – December period of the current financial year.  The government has decided to retain 100 per cent foreign direct investment in both greenfield (new) and brown field (existing) pharmaceutical companies, despite concerns over genetic drugs going out of production, if multi-national companies take over domestic ones. In M&A deals, a non compete clause would not be allowed, except in special circumstances. The Department of Industrial Policy and Promotion plans to release the next edition of its consolidated foreign direct investment policy document on March 31, incorporating changes made in the past year. DIPP compiles all policies related to India’s FDI regime into a single document to make it easy for investors to understand. 185 million estimated number of mobile internet users in India by June 2014, according to a report by the Internet & Mobile Association of India and IMRB International.  India had 110 million mobile internet users with 25 million in rural areas. $3.77 tn estimated global IT spending in 2014, according to research firm Gartner Inc. The growth forecast for this year is cut to 3.1 %from the earlier estimate of 3.5 %. The spending growth forecast for telecom services – a segment that accounts for more than 40 % at total IT spending – from 1.9 per cent to 1.2 per cent is the main reason for this overall IT cut. A Reserve Bank of India committee has recommended setting up a special category of lenders who would cater to small businesses and households, to expand the number of customers with access to banking services. These banks would focus onproviding payment services and deposit products.  Indian banks want the free use of automated teller machines to be capped at five transactions in a month including that of the bank in which the account is active. This follows state government order to banks to install security guards at ATM booths after a woman banker was assaulted in Bangalore. The government is likely to present a vote on Account in mid-February. The annual Economic Survey will be tabled later in Parliament along with the full Budget. A full Budget for 2014/15 is likely to be present in July by the new government formed after the General Election. The government will soon launch an internet spy system, called Netra, to detect malafide messages. Security agency will deploy the system to capture dubious voice traffic on applications such as Skype and Google Talk, as well as tweeters.

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CARE

Rating

Long Term Bank Facility = A

Rating Explanation

Adequate degree of safety and low credit risk.

Date

20.06.2013

 

Rating Agency Name

CARE

Rating

Short Term Bank Facility = A2

Rating Explanation

Strong degree of safety and low credit risk.

Date

20.06.2013

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

LOCATIONS

 

Registered / Corporate Office :

7-2-A2, Hetero Corporate Industrial Estate, Sanathnagar, Hyderabad – 500018, Andhra Pradesh, India 

Tel. No.:

91-40-23704923/ 24/ 25/ 26 / 23707171 / 7272 / 7744

Fax No.:

91-40-23704926/ 23714250

E-Mail :

contact@heterodrugs.com

ramu@heterodrugs.com

vasucs@heterodrugs.com

sambhram.p@heterodrugs.com

Website :

http://www.heterodrugs.com

Area :

3000 Sq. ft.

Location :

Owned

 

 

Regional Office:

‘Hetero Drugs Limited’ 607/608, 6th Floor, Matharu Arcade, Subhash Road, Ville Parle (East), Mumbai – 400 057, Maharashtra, India

Tel. No.:

91-22-56910809

Fax No.:

91-22-26845709

 

 

Marketing Office:

Located at:

·         USA

·         Russia

·         Europe

·         China

·         Thailand

·         UAE

·         Egypt

·         South Africa

 

 

DIRECTORS

 

As on 05.09.2013

 

Name :

Dr. Bandi Partha Saradhi Reddy

Designation :

Managing Director

Address :

Plot No. 389, Road No. 22/B, Jublihills Chequepost, Madhapoor Road, Hyderabad – 500038, Andhra Pradesh, India

Date of Birth/Age :

06.03.1954

Qualification :

Ph.d in organic chemistry

Date of Appointment :

05.12.1996

DIN No.:

00015899

PAN No. :

AAJPB7067K

 

 

Name :

Mr. Srinivas Reddy Male

Designation :

Director

Address :

Plot No.933, Vivrkanandnagar, Kukatpally, Hyderabad- 500 072, Andhra Pradesh, India

Date of Birth/Age :

02.02.1973

Qualification :

MBA. Marketing

Date of Appointment :

01.08.2013

DIN No.:

00016085

 

 

Name :

Mr. Krishna Bandi Vamsi

Designation :

Whole-time director

Address :

Plot No.389, Road No.22/B, Jubilee Hills, Check-Post, Hyderabad-500 033, Andhra Pradesh, India

Date of Birth/Age :

31.07.1983

Qualification :

MS in Chemical Engineering

Date of Appointment :

10.04.2008

DIN No.:

01014619

PAN No. :

AIPPB1881R

 

 

Name :

Mr. Attunri Venkata Narasa Reddy

Designation :

Whole Time Director

Address :

H. No. 8-3-678/61, Pragathi Nagar Colony, Yosufguda, Hyderabad – 500018, Andhra Pradesh, India

Date of Birth/Age :

21.12.1963

Qualification :

MSc

Date of Appointment :

11.03.1999

DIN No.:

00023432

 

 

Name :

Mr. Chilukuri Mohan Reddy

Designation :

Whole Time Director

Address :

Plot No.54, Green Avenue, Nizampet Road, Nizampet, Hyderabad – 500000, Andhra Pradesh, India

Date of Birth/Age :

02.01.1969

Qualification :

M. Pharm c

Date of Appointment :

18.11.1999

DIN No.:

00208921

 

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 05.09.2013

 

Names of Shareholders

 

No. of Shares

B. Partha Saradhi Reddy

 

282860

B. Kalavathi

 

160740

M. Krishna Sinduri

 

150000

B. Vamsi Krishna

 

398000

M. Srinivas Reddy

 

200

B. Srinivas Reddy

 

200

B. Soma Kantham

 

200

M. Krishna Karthikeya Reddy

 

146900

B. Anvida

 

46000

M. Krishna Sahithi

 

146900

Total

 

1332000

 

As on 05.09.2013

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage

Directors or relatives of Directors

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Active Pharmaceutical Ingredients (APIs) and Finished Dosages Formulations (FDF).

 

 

Products :

Production Description

 

ITC Code No

Bulk Drugs and Drug Intermediates

294110

Pharmaceuticals Formulation

300410

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available

 

 

Bankers :

·         DBS Bank Limited, Salarpuria Windsor, No.3, Ulsoor Road, Bengaluru - 560042, Karnataka, India

 

·         State Bank of Hyderabad, Sanathnagar Branch, Industrial Estate, Sanathnagar, Hyderabad -500018, Andhra Pradesh, India

 

·         Andhra Bank, Specialised Corporate Finance Branch, 3rd Floor, Padmaja Land Mark, Somajiguda, Hyderabad - 500082, Andhra Pradesh, India

 

·         Export-Import Bank OF India, Centre One Building, Floor 21, World Trade Centre Complex, Cuffe Parade, Mumbai - 400005, Maharashtra, India

 

 

Facilities :

(Rs. In Millions)

Secured Loan

As on

31.03.2013

As on

31.03.2012

Long-term borrowings

 

 

Rupee term loans from banks

(The Term Loans are secured by a Pari-passu first charge on all fixed assets of the company both present and future and second charge on current assets of the company)

1452.051

1168.750

Foreign currency term loans from banks

(The Term Loans are secured by a Pari-passu first charge on all fixed assets of the company both present and future and second charge on current assets of the company)

2107.542

1599.436

Short-term borrowings

 

 

Working capital loans from banks

8065.918

5603.571

Total

11625.511

8371.757

 

 

 

Banking Relations :

---

 

 

Auditors :

 

Name :

M. V. Narayana Reddy and Company

Chartered Accountants

Address :

D. No. 8-3-941, Flat No. 504, Vijayasree Apartments, Opposite Kamma Sangham, Ameerpet, Hyderabad – 500073 Andhra Pradesh, India

Tel. No.:

91-40-23743975 / 23744448

PAN No.:

AADFM4830F

 

 

Enterprises which are owned, or have significant influence of or are partners with Key management personnel and their relatives

·         Cirex Pharmaceuticals Limited

·         Clinse Labs Private Limited

·         Genx Pharma Limited

·         Hetero Drugs Limited

·         Hetero Healthcare Limited

·         Symed Labs Limited

·         Chemi Pack (India) Private Limited

·         Hetero Med Solutions Limited

·         Camber Pharmaceuticals Inc

·         Invagen Pharmaceuticals Inc

·         Hetmak Fzco

·         Akar International Fzc

·         Mint Pharmaceuticals Inc.

·         Honour Lab Limited

 

 

Associate

·         Hetero Infrastructure Sez Limited

·         Hetero (Thailand) Limited

·         Hetero Singapore Pte Limited

·         Hetero Usa Inc

·         Hetero Europe SL

·         Arapharma Group S A

 

 

Subsidiary company

·         Hetero Fzco

·         Hetero Wind Power Limited

 

 

Joint venture

Pharmed Healthcare

 

 

Fellow Subsidiary company

HETLABS MEXICO

 

 

CAPITAL STRUCTURE

 

As on 05.09.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1500000

Equity Shares

Rs.10/- each

Rs. 15.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1332000

Equity Shares

Rs.10/- each

Rs.13.320 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

31.03.2012

31.03.2011

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

13.320

13.320

13.320

(b) Reserves & Surplus

11449.970

9651.664

8079.638

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

11463.290

9664.984

8092.958

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

3559.593

2768.186

1871.312

(b) Deferred tax liabilities (Net)

1071.107

735.668

465.685

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

74.408

49.947

27.385

Total Non-current Liabilities (3)

4705.108

3553.801

2364.382

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

9435.509

7778.435

5491.996

(b) Trade payables

4808.864

3973.460

2814.553

(c) Other current liabilities

2563.013

1740.904

1266.428

(d) Short-term provisions

110.382

78.292

112.525

Total Current Liabilities (4)

16917.768

13571.091

9685.502

 

 

 

 

TOTAL

33086.166

26789.876

20142.842

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

9919.286

7789.060

5015.159

(ii) Intangible Assets

17.902

21.693

7.013

(iii) Capital work-in-progress

1477.436

2373.585

3333.011

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

888.107

391.607

372.062

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

1100.254

1019.898

820.495

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

13402.985

11595.843

9547.740

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

9310.699

7382.000

6346.062

(c) Trade receivables

9287.243

6686.970

2989.745

(d) Cash and cash equivalents

189.817

230.974

206.154

(e) Short-term loans and advances

57.224

68.187

68.761

(f) Other current assets

838.198

825.902

984.380

Total Current Assets

19683.181

15194.033

10595.102

 

 

 

 

TOTAL

33086.166

26789.876

20142.842

 


 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

Income

27605.375

20381.480

15253.977

 

 

Other Income

291.542

47.902

127.295

 

 

TOTAL                                     (A)

27896.917

20429.382

15381.272

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of material consumed

14987.593

13605.379

11348.537

 

 

Purchase of stock in trade

457.716

344.046

8.521

 

 

Changes in inventories of finished goods, work-in-progress and stock-in-trade

746.357

(1905.332)

(827.398)

 

 

Employee benefit expenses

1466.736

980.549

504.695

 

 

Other expenses

5541.959

3786.144

1384.635

 

 

TOTAL                                     (B)

23200.361

16810.786

12418.990

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

4696.556

3618.596

2962.282

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

1465.230

870.777

321.686

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

3231.326

2747.819

2640.596

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

524.330

398.001

193.656

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

2706.996

2349.818

2446.940

 

 

 

 

 

Less

TAX                                                                  (H)

878.712

749.832

581.232

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

1828.284

1599.986

1865.708

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

105.661

66.635

31.891

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Transfer to General Reserve

1710.000

1530.000

1800.000

 

 

Dividend

29.980

30.960

30.962

 

BALANCE CARRIED TO THE B/S

193.965

105.661

66.635

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

16929.380

7951.180

2510.578

 

TOTAL EARNINGS

16929.380

7950.180

2510.578

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

7644.620

4842.990

4619.259

 

 

Capital Goods

139.600

519.760

0.000

 

 

Others

83.830

4.840

0.000

 

TOTAL IMPORTS

7868.050

5367.590

4619.259

 

 

 

 

 

 

Earnings Per Share (Rs.)

1372.59

1201.19

1400.68

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

PAT / Total Income

(%)

6.55

7.83

12.13

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

9.81

11.53

16.04

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

8.81

9.78

14.89

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.24

0.24

0.30

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

1.13

1.09

0.91

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.16

1.12

1.09

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

Yes

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

----------------------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

----------------------

22]

Litigations that the firm / promoter involved in

Yes

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

----------------------

26]

Buyer visit details

----------------------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

 

LITIGATIONS DETAILS

 

CEA 40 / 2006

CEASR 3632 / 2005

CASE IS:PENDING

 

PETITIONER

 

RESPONDENT

COMMISSIONER OF CENTRAL EXCISE, HYD-I COMMISSIONERATE

  VS

HETERO DRUGS LTD, MEDAK DISTRICT, A.P.

PET.ADV. : SARADA

 

RESP.ADV. : VIJAY

SUBJECT: CENTRAL EXCISE APPEAL

 

DISTRICT:  HYDERABAD

 

 

FILING DATE:  22-11-2005

POSTING STAGE :  FOR HEARING

 

REG. DATE    :   09-03-2006

LISTING DATE :  18-02-2014

STATUS   :  ---------

 

HON'BLE JUDGE(S):

G.CHANDRAIAH    

CHALLA KODANDA RAM   

 

 

 

 

NOTE:

 

The Registered office of the company has been shifted from H. No.8-3-166/1 and 2, Challa Estates, First Floor, Erragadda Hyderabad – 500018, Andhra Pradesh, India  to the present address w.e.f. 31.07.2009.

 

 

REVIEW OF PERFORMANCE:

 

The Company has recorded its highest ever revenue of Rs.27896.917 Millions Earnings Before Interest, Tax, Depreciation and Amortisation (EBIDTA) recorded a growth of 29.79 % to reach Rs.4696.556 Millions. and Profit After Tax (PAT) grew to Rs.1828.284 Millions. recording a growth of 14.27 % over Rs.1599.986 Millions. achieved in the previous year despite the challenges in some of the major markets, increased power costs and foreign exchange impact due to depreciation of the rupee against major currencies.

 

The Company's formulation business increased to Rs.18641.250 Millions. during the fiscal, compared to Rs.14535.140 Millions during 2011-12. Formulation revenues were higher by 28.25% over the previous year on account of increase in formulation operations. Exports increased to Rs.17738.270 Millions. As compared to Rs.8138.250 Millions. in the previous year registering an export growth of 117.96%.

 

The Company incurred finance cost of Rs.1465.230 Millions during the year which is 68% higher than the previous year on account of increase in volume of operations and costs as well as higher cost of borrowings together with depreciation of rupee against major currencies.

 

Due to non availibility of adequate power from the government grid despite increase in tariff, the Company purchased power through open access. Accordingly the power and fuel costs stand increased to Rs1247.600 Millions. for the year as against Rs.707.530 Millions for the previous year.

 

In respect of investments made in M/s. Janani Infrastructure Limited and M/s. Jagati Publications Private Limited, the Central Bureau of Investigation and Directorate of Enforcement has filed case against the Company together with other investors. The Company in consultation with legal experts opines that the case is unsustainable. Further, it will not have any financial impact on current or future operations of the Company.

 

OUTLOOK

 

People, Products, Infrastructure and improved relationship with some of the big pharma companies across the globe are the key drivers for the growth of the Company. Further there is a continuous emphasis on marketing niche products keeping cost under control with high end customer satisfaction .The order book for API and finished dosages is robust with visibility of healthy earnings for several months ahead.

 

The consistant efforts of higher margins, lower costs, improved cycle time on the production floor are estimated to enhance the bottom line in the years to come.

 

The Power Purchase Agreement (PPA) entered into with Hetero Wind Power Limited for supply of electricity on long term basis will enable the Company to overcome substantially the power deficit scenario being experienced in the State of Andhra Pradesh.

 

UNSECURED LOAN

Rs. In Millions

Particular

As on

31.03.2013

As on

31.03.2012

Short-term borrowings

 

 

Loans repayable on demand from banks

1369.591

2174.864

Total

1369.591

2174.864

 

 

 

 

 

 

INDEX OF CHARGES

 

S.No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

 

Charge Holder

Address

Service Request Number (SRN)

1

10421516

27/03/2013

750,000,000.00

STATE BANK OF INDIA

INDUSTRIAL FINANCE BRANCH, RAJ BHAVAN ROAD, SOMAJIGUDA, HYDERABAD, Andhra Pradesh - 500082, INDIA

B73690208

2

10308989

14/09/2011

250,000,000.00

STATE BANK OF MYSORE

INDUSTRIAL FINANCE BRANCH, MY HOME JUPALLY, AMEERPET, HYDERABAD, Andhra Pradesh - 500038, INDIA

B22035851

3

10283954

20/07/2012 *

8,580,000,000.00

ANDHRA BANK

Specialized Corporate Finance, 6-3-648,3rd Floor, Padmaja Land Mark, Somajiguda, Hyderabad, Andhra Pradesh - 500082, INDIA

B45697646

4

10283970

26/03/2011

500,000,000.00

ANDHRA BANK

Specialised Corporate Finance Branch, 3rd Floor,
Padmaja Land Mark, Hyderabad, Andhra Pradesh - 500082, INDIA

B12030003

5

10273568

29/12/2011 *

1,000,000,000.00

EXPORT-IMPORT BANK OF INDIA

CENTRE ONE BUILDING, FLOOR 21, WORLD TRADE CENTRE, CUFFE PARADE, MUMBAI, Maharashtra - 400005, INDIA

B28834844

6

10257057

07/12/2010

500,000,000.00

ANDHRA BANK

SPECIALISED CORPORATE FINANCE BRANCH, 3rd FLOOR, PADMAJA LAND MARK, SOMAJIGUDA, HYDERABAD, Andhra Pradesh - 500082, INDIA

B01508654

7

10257800

16/11/2010

500,000,000.00

STATE BANK OF HYDERBAD

SANATHNAGAR BRANCH, INDUSTRIAL ESTATE, SANATHNAGAR, HYDERABAD, Andhra Pradesh - 500018, INDIA

B00572214

8

10249418

28/09/2010

500,000,000.00

STATE BANK OF INDIA

INDUSTRIAL FINANCE BRANCH, RAJ BHAVAN ROAD, SOMAJIGUDA, HYDERABAD, Andhra Pradesh - 500082, INDIA

A98495476

9

10242113

20/08/2010

864,000,000.00

ANDHRA BANK

Specialised Corporate Finance Branch, 3rd Floor,
Padmaja Land Mark, Somajiguda, Hyderabad, Hyderabad , Andhra Pradesh - 500018, INDIA

A95186813

10

10151351

29/09/2011 *

3,017,500,000.00

STATE BANK OF HYDERABAD

SANATHNAGAR BRANCH, INDUSTRIAL ESTATE, SANATHNAGAR, HYDERABAD, Andhra Pradesh - 500018, INDIA

B24688715

11

10112415

24/06/2008

300,000,000.00

STATE BANK OF MYSORE

INDUSTRIAL FINANCE BRANCH, 2nd FLOOR MYHOMEJUPALLY, OPP:GREEN PARK, AMEERPET, HYDERABAD, Andhra Pradesh - 500038, INDIA

A41873324

12

10089092

27/02/2013 *

15,475,000,000.00

ANDHRA BANK

SPECIALISED CORPORATE FINANCE BRANCH, PADMAJA LAND MARK, SOMAJIGUDA, HYDERABAD, Andhra Pradesh - 500082, INDIA

B71300685

13

10024362

29/09/2006

27,500,000.00

BANK OF INDIA

KHAIRATABAD BRANCH, PTI BUILDING, MASAB TANK, HYDERABAD, Andhra Pradesh - 500082, INDIA

A06209761

14

90134916

18/07/2005

20,000,000.00

ANDHRA BANK

SCF BRANCH, SOMAJIGUDA, HYDERABAD, Andhra Pradesh
, INDIA

-

15

90136359

19/04/2012 *

3,650,000,000.00

STATE BANK OF HYDERABAD

SANATHNAGAR BRANCH, INDUSTRIAL ESTATE, SANATHNAGAR, HYDERABAD, Andhra Pradesh - 500018, INDIA

B38544425

16

90134803

25/08/2004

150,000,000.00

ANDHRA BANK

SCF BRANCH, SOMAJIGUDA, HYDERABAD, Andhra Pradesh
, INDIA

-

17

90134769

15/04/2004

30,000,000.00

ANDHRA BANK

SCF BRANCH, HYDERABAD, Andhra Pradesh, INDIA

-

18

90133173

10/03/2004

15,000,000.00

BANK OF INDIA

PTI BUILDING ; KHAIRTABAD BRANCH, HYDERABAD, Andhra Pradesh, INDIA

-

19

90136267

11/02/2009 *

970,000,000.00

STATE BANK OF HYDERABAD

SANATHNAGAR BRANCH, INDUSTRIAL ESTATES, SANATHNAGAR, HYDERABAD, Andhra Pradesh - 500018, INDIA

A57977472

20

90133138

06/10/2003

12,500,000.00

BANK OF INDIA

PTI BUILDING ; KHAIRTABAD BRANCH, HYDERABAD, Andhra Pradesh, INDIA

-

21

90133086

13/03/2003

10,000,000.00

BANK OF INDIA

PTI BUILDING ; KHAIRTABAD BRANCH, HYDERABAD, Andhra Pradesh, INDIA

-

22

90136146

15/11/2002 *

75,000,000.00

BANK OF BAHRAIN AND KUWAIT BSC

6-3-550; SOMAJIGUDA, HYDERABAD, Andhra Pradesh - 500082, INDIA

-

23

90132759

27/03/2000 *

40,000,000.00

INDUSTRIAL DEVELOPMENT BANK OF INDIA

IDBI TOWER, CUFFE PARADE, MUMBAI, Maharashtra - 400005, INDIA

-

24

90135924

13/12/1999

40,000,000.00

INDUSTRIAL DEVELOPMENT BANK OF INDIA

IDBI TOWER ; CUFFE PARADE ; COLABAS, MUMBAI, Maharashtra - 400005, INDIA

-

25

90135802

18/02/2010 *

3,150,000,000.00

ANDHRA BANK

SPECIALISED CORPORATE FINANCE BRANCH, 3rd FLLOR, PADMAJA LAND MARK, SOMAJIGUDA, HYDERABAD, Andhra Pradesh - 500082, INDIA

A81579674

26

90135776

17/04/2001 *

24,500,000.00

ANDHRA BANK

INDUSTRIAL FINANCE BRANCH; "X" ROADS; AMEERPET, PANCOM BUSINESS CENTRE, HYDERABAD, Andhra Pradesh, INDIA

-

27

90131719

21/03/1990

200,000.00

A.P. STATE FINANCIAL CORPORATION

CHIRAG ALI LANE, HYDERABAD, Andhra Pradesh, INDIA

-

28

90131075

21/03/1990

3,870,000.00

A.P. STATE FINANCIAL CORPORATION

CHIRAG ALI LANE, HYDERABAD, Andhra Pradesh, INDIA

-

 

* Date of charge modification

 

 

FIXED ASSETS

 

·         Land and Site Development

·         Factory Building

·         Electrical Equipment

·         R and D Equipment

·         ETP Machinery

·         Furniture and Fixture

·         Office Equipments

·         Vehicles

·         Computers  

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.62.32

UK Pound

1

Rs.101.78

Euro

1

Rs.84.68

 

 

INFORMATION DETAILS

 

Report Prepared by :

NTH

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

6

--RESERVES

1~10

6

--CREDIT LINES

1~10

6

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

YES

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

54

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.